Some new discoveries and progress are being seen continuously in medical science. Cancer has long been considered an incurable disease; But recently researchers have found an effective drug that works against this disease. According to a research published in the New England Journal of Medicine on June 6, researchers in clinical trials have found a major achievement in the fight against rectal cancer.
According to research, by taking 6 months of this claim by patients suffering from rectal cancer, the cancer is cured 100 percent. In initial trials, this drug is 100% working and at present the trial is going on on this drug. According to a report in the New York Times, in a clinical trial, a drug named Dostarlimab was tested on 18 patients for about 6 months, and when this trial ended, it was found that the tumor was almost almost eliminated in all. Gone.
how medicine works
Dosterlimab medicine is a monoclonal antibody. This antibody has been made in the laboratory. These antibodies work to fight a specific disease. According to the researchers, the dosterlimumab antibody sticks to the cancer cells. Due to this the hidden cancer cells are visible to the body’s immune system and it kills them. For information, let us tell you that dosterlimab is specifically designed to block a specific protein involved in cancer cells called PD-1.
According to the researchers, all the cancer patients in the study had mismatch repair deficiencies. In this condition, many new cells start forming rapidly in the body of the patients, due to which the body is unable to cure them, later these cells take the form of cancer. Mismatch repair deficiency occurs in 10% of patients with rectal cancer. In such a situation, it is seen that this medicine is nothing less than a miracle in this disease.
how was the drug trial
According to the researchers, dosterlimumab was administered to the patients every three weeks for six months. During the research, doctors also conducted a number of follow-up tests including physical examination of patients, MRI scans and PET scans. Researchers found that after 6 months the cancer was completely eradicated in all the patients.
The endoscopy test also showed no signs of cancer. At the same time, according to the researchers, these 18 patients may now have to go through a second trial for the next step. However, now they do not require any special treatment.
dosterlimab medicine price
Talking about the price of this medicine, the price of Dosterlimab 500 MG in the US is $ 11,000, around Rs 8,54,859. However, after this successful research, it is being said to make it available at a discount.